Replacing lower debt/equity strategy with higher earnings revisions Complement earnings revisions with greater interest coverage, stronger price momentum, and higher free cash flow/enterprise value Favored Stocks Include: Nestle, Novartis, LVMH, Roche, Allianz, GlaxoSmithKline, Reckitt Benckiser, Prudential
Complete the form and a member of our team will send you a copy of this publication.
While you wait, explore additional NDR research and solutions.
Institutional Investors
Custom Research
Wealth Managers
Stock Selection
ETF Selection
Please note that you are using an unsupported browser. While the site will continue to function, you might experience sub-optimal behavior until you upgrade. Please update your browser to a later version for a better experience.